Example: marketing
A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, …

A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, …

Back to document page

Short Title: A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines)

Download A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, …


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries